City's faith in Glaxo
Article Abstract:
Glaxo Wellcome has seen a drop in price for Zantac, but brokers are relatively optimistic about the company's stocks, with no sellers in a sample of six. BZW is a buyer and Merrill Lynch is a buyer in the long term. Salomon Brothers argues for maintaining holdings over the short term and buying over the long term. Charles Stanley is cautious and a long-term buyer, as is Societe General Strauss Turnbull, which is holder over the short term. Morgan Stanley sees Glaxo as benefiting from a range of income sources and is a buyer.
Publication Name: Investors Chronicle
Subject: Business
ISSN: 0261-3115
Year: 1997
User Contributions:
Comment about this article or add new information about this topic:
Can SB cope on its own?
Article Abstract:
SmithKline Beecham has suffered two failed mergers, and stockbrokers are divided on the companies' stocks' prospects. Two brokers from a sample of six rate the company's stocks a sell, two rate them a hold, and two rate them a buy. The sellers are Lehman Brothers and Panmure Gordon, the holders are Merrill Lynch and SG Securities, and the buyers are Sutherlands and Credit Lyonnais. Both buyers see a likelihood of coporate activity, with lack of stockholder loyalty making this more likely.
Publication Name: Investors Chronicle
Subject: Business
ISSN: 0261-3115
Year: 1998
User Contributions:
Comment about this article or add new information about this topic:
Merck: premium rating
Article Abstract:
Merck plans to float a 25% stake in the company, and will still be controlled by family interests which have been involved in the company since it was established in the 17th century. The share offer will raise funds for expansion and the company seeks to strengthen its position in the generic drugs market which may involve an acquisition in the US. Merck AG is a holding company for the group and stock holders are invited to swap shares for shares in Merck.
Publication Name: Investors Chronicle
Subject: Business
ISSN: 0261-3115
Year: 1995
User Contributions:
Comment about this article or add new information about this topic:
- Abstracts: Company facts: Danone. GrandMet spices up its act
- Abstracts: Company facts: Time Warner. Sunny prospects. Flextech
- Abstracts: Macroeconomic risk and the determination of expected returns on stocks. R/S analysis and long term dependence in stock market indices
- Abstracts: Selecting for growth. A man for all seasons?
- Abstracts: Workers unite: the unions are back. Time to get loaded